Bay Street News, November, 2018

Luxturna* (voretigene neparvovec) is the first gene therapy to treat an inherited retinal disease, indicated for children and adults with […]

LUXTURNA is first gene therapy for a genetic disease approved in both the U.S. and EU LUXTURNA is first and […]

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Nov. […]

VANCOUVER, British Columbia, Nov. 22, 2018 (GLOBE NEWSWIRE) — Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for […]

FORT ST. JOHN, British Columbia, Nov. 22, 2018 (GLOBE NEWSWIRE) — Macro Enterprises Inc. (TSX-V: MCR) –   Summary of […]

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 22, 2018 (GLOBE NEWSWIRE) — […]

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Nov. 22, 2018 […]

CALGARY, Alberta, Nov. 22, 2018 (GLOBE NEWSWIRE) — CORDY OILFIELD SERVICES INC. (the “Corporation” or “Cordy”) (CKK: TSX-V) released today […]

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MISSISSAUGA, Ontario, Nov. 22, 2018 (GLOBE […]

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MISSISSAUGA, Ontario, Nov. 22, 2018 (GLOBE […]